Safety and Feasibility of Early Discharge for Transfemoral Transcatheter Aortic Valve Replacement (SAFETAVR)The purpose of this study is to determine the efficacy, safety and feasibility of next day discharge in patients undergoing self-expandable transfemoral TAVR utilizing the Vancouver 3M Clinical Pathway. Recruiting Principal Investigator David WoodBody Locations and Systems HeartArea Vancouver
AMPLATZER Patent Foramen Ovale (PFO) Occluder Post Approval Study (PFO PAS)The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ Patent Foramen Ovale (PFO) Occluder in the post Approval Setting. Recruiting Principal Investigator David WoodBody Locations and Systems HeartArea VancouverAge 18-60
